CausalSentinel

Protein Dossier — MGAT2 (Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Forced vital capacity (FVC) 0.0345 0.0102 6.90e-04 Wald ratio 1 cis NA
Forced expiratory volume in 1-second (FEV1) 0.033 0.0107 0.00207 Wald ratio 1 cis NA
Height 0.0405 0.0149 0.00645 Wald ratio 1 cis NA
Urate -0.0718 0.0272 0.00825 Wald ratio 1 cis NA
Transferrin 0.137 0.0523 0.00885 Wald ratio 1 cis NA
Non-cancer illness code self-reported: anxiety or panic attacks 0.219 0.0864 0.0111 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.123 0.0488 0.0119 Wald ratio 1 cis NA
Bipolar disorder -0.299 0.12 0.0126 Wald ratio 1 cis NA
Cancer code self-reported: malignant melanoma 0.27 0.109 0.013 Wald ratio 1 cis NA
Squamous cell lung cancer 0.326 0.133 0.0146 Wald ratio 1 cis NA
Non-cancer illness code self-reported: asthma -0.0918 0.0381 0.0159 Wald ratio 1 cis NA
Caudate volume -58.6 25.2 0.0199 Wald ratio 1 cis NA
…and 105 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

No GWAS Catalog associations mapped to this gene.

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 629 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
MGAT2-congenital disorder of glycosylation 0.834 established (curated) no MR -> candidate analysis
Abnormal facial shape 0.426 established (curated) no MR -> candidate analysis
Global developmental delay 0.426 established (curated) no MR -> candidate analysis
Abnormal glycosylation 0.426 established (curated) no MR -> candidate analysis
hereditary disease 0.316 established (curated) no MR -> candidate analysis
autoimmune disorder of musculoskeletal system 0.104 common-variant locus no MR -> candidate analysis
corneal neovascularization 0.098 common-variant locus no MR -> candidate analysis
Abnormality of the gastrointestinal tract 0.095 common-variant locus no MR -> candidate analysis
lagophthalmos 0.094 common-variant locus no MR -> candidate analysis
liver disorder 0.094 common-variant locus no MR -> candidate analysis

Of the 10 rows above, 10 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase)
gnomAD constraint pLI=0.0093, LOEUF=0.755 — LoF-tolerant
GWAS Catalog 21 unique SNPs / 42 rows
ClinVar 185 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance